
Wilson disease in the USA: epidemiology and real-world patient ...
2024年12月22日 · Objectives: To describe the epidemiology, patient characteristics and comorbidities in patients with Wilson disease (WD) in the USA. Design: Retrospective, …
Effects of Helicobacter pylori treatment and vitamin and garlic ...
2019年9月11日 · Conclusions: H pylori treatment for two weeks and vitamin or garlic supplementation for seven years were associated with a statistically significant reduced risk of …
Mortality due to cancer treatment delay: systematic review and …
2020年11月4日 · Objective: To quantify the association of cancer treatment delay and mortality for each four week increase in delay to inform cancer treatment pathways. Design: Systematic …
Are the 5-hydroxymethylcytosine-based wd-scores really superior …
We read with interest the recent article by Cai et al 1 describing the development of 5-hydroxymethylcytosine (5hmC)-based wd-scores that have better accuracy in diagnosing early …
Wilson disease in the USA: epidemiology and real-world ... - BMJ …
Wilson disease (WD) is an autosomal recessive condition which leads to an excessive copper deposition in body organs, particularly in the liver and the central nervous system. 1 This …
⇒ This study estimated the diagnosed prevalence of Wilson disease (WD) for the first time in the USA, by using a large, nationally representative claims database. The real- world nature of the …
Enterovirus infection and type 1 diabetes mellitus: systematic …
2011年2月3日 · Objective: To review the association between current enterovirus infection diagnosed with molecular testing and development of autoimmunity or type 1 diabetes. …
P21 Monitoring maintenance therapy with D-Penicillamine for …
D-penicillamine (DPA) is first line therapy for WD. Monitoring is conducted by performing 24-hour urinary copper excretions (UCE) and titrating the dose depending on the amount of copper …
Reply to ‘Are the 5-hydroxymethylcytosine-based wd-scores ... - Gut
Notably, the 5hmC-based wd-scores consistently outperformed AFP in both training and validation sets for HCC versus non-HCC, early HCC versus CHB/LC, and early HCC versus controls …
Mortality due to cancer treatment delay: systematic review ... - The BMJ
2020年11月4日 · Our analysis aims to provide robust evidence to guide national policy making, specifically the prioritisation and organisation of cancer services, by investigating the …